[Diagnostic tests: Anti-neuronal nuclear antibodies, type 1 and type 2].
Hirose
Genjiro
G
Department of Neurology, Kanazawa Medical University.
D000974:Antibodies, Antinuclear / Q000097:blood* / Q000134:cerebrospinal fluid*; D000951:Antigens, Neoplasm / Q000276:immunology*; D015415:Biomarkers / Q000097:blood / Q000134:cerebrospinal fluid; D026481:Blotting, Far-Western; D051959:ELAV Proteins; D006801:Humans; D007150:Immunohistochemistry / Q000379:methods; D009419:Nerve Tissue Proteins / Q000276:immunology*; D000090682:Neuro-Oncological Ventral Antigen; D020361:Paraneoplastic Syndromes, Nervous System / Q000175:diagnosis* / Q000276:immunology; D016601:RNA-Binding Proteins / Q000276:immunology*; D013194:Staining and Labeling / Q000379:methods
D000974:Antibodies, Antinuclear; D000951:Antigens, Neoplasm; D015415:Biomarkers; D051959:ELAV Proteins; D009419:Nerve Tissue Proteins; D000090682:Neuro-Oncological Ventral Antigen; D016601:RNA-Binding Proteins